Nitric oxide (NO) has been implicated as mediator in a variety of phys
iological functions, including neurotransmission, platelet aggregation
, macrophage function, and vasodilation. The consumption of NO by extr
acellular hemoglobin and subsequent vasoconstriction have been suggest
ed to be the cause of the mild hypertensive events reported during in
vivo trials of hemoglobin-based O-2 carriers. The depletion of NO from
endothelial cells is most likely due to the oxidative reaction of NO
with oxyhemoglobin in arterioles and surrounding tissue, In order to d
etermine the mechanism of this key reaction, we have measured the kine
tics of NO-induced oxidation of a variety of different recombinant spe
rm whale myoglobins (Mb) and human hemoglobins (Hb). The observed rate
s depend linearly on [NO] but show no dependence on [O-2]. The bimolec
ular rate constants for NO-induced oxidation of MbO(2) and HbO(2) are
large (k'(ox,NO)=30-50 mu M(-1) s(-1) for the wild-type proteins) and
similar to those for simple nitric oxide binding to deoxygenated Mb an
d Hb, Both reversible NO binding and NO-induced oxidation occur in two
steps: (1) bimolecular entry of nitric oxide into the distal portion
of the heme pocket and (2) rapid reaction of noncovalently bound nitri
c oxide with the iron atom to produce Fe2+-N=O or with Fe2+-O-O-delta-
to produce Fe3+-OH2 and nitrate, Both the oxidation and binding rate
constants for sperm whale Mb were increased when His(E7) was replaced
by aliphatic residues. These mutants lack polar interactions in the di
stal pocket which normally hinder NO entry into the protein. Decreasin
g the volume of the distal pocket by replacing Leu(B10) and Val(E11) w
ith aromatic amino acids markedly inhibits NO-induced oxidation of MbO
(2). The latter results provide a protein engineering strategy for red
ucing hypertensive events caused by extracellular hemoglobin-based O-2
carriers, This approach has been explored by examining the effects of
Phc(B10) and Phe(E11) substitutions on the rates of NO-induced oxidat
ion of the alpha and beta subunits in recombinant human hemoglobin.